Get Started
Deal Browser
Listings + public signals
Public Signals
Auto-discovered deal flow
Browse Startups
Companies raising now
Deal Types
Every stage, every vertical
Investor Types & Accreditation
Who's in the network
For Founders
Raise your round
For Investors
Source your next deal
For Service Providers
List your firm
About
Our story & leadership
Events & Partners
GCN conferences & private dinners
Quality Standards
What it takes to get listed
Contact
Get in touch
How To List Your Startup
Step-by-step founder guide
FAQ
Common questions, answered
Disclaimer
Legal & platform disclosures
Pricing
Get Started
← All deals
PersonAuto-indexed · Unverified

Stephen Bloch

New Haven, US· Director, Executive Officer

Named on 6 public capital-raising filings across 2 companies. Compiled automatically from public SEC filings — not verified by this individual.

Companies

Allyx Therapeutics, Inc.EvolveImmune Therapeutics Holding Company, LLC

Filings (6)

Allyx Therapeutics, Inc. raised $26.4M
Allyx Therapeutics, Inc.· Director· May 11, 2026
Company raise
Allyx Therapeutics, Inc. raised $26.4M
Allyx Therapeutics, Inc.· Executive Officer· May 11, 2026
Company raise
Allyx Therapeutics, Inc. raised $3.3M
Allyx Therapeutics, Inc.· Director· Mar 3, 2026
Company raise
Allyx Therapeutics, Inc. raised $3.3M
Allyx Therapeutics, Inc.· Executive Officer· Mar 3, 2026
Company raise
EvolveImmune Therapeutics Holding Company, LLC raised $20.0M
EvolveImmune Therapeutics Holding Company, LLC· Director· Nov 1, 2024
Company raise
EvolveImmune Therapeutics Holding Company, LLC raised $20.0M
EvolveImmune Therapeutics Holding Company, LLC· Executive Officer· Nov 1, 2024
Company raise